Spironolactone Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Rats

Spironolactone Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Rats

Spironolactone (SPR) has been shown to protect diabetic cardiomyopathy (DCM), but the specific mechanisms are not fully understood. Here, we determined the cardioprotective role of SPR in diabetic mice and further explored the potential mechanisms in both in vivo and in vitro models. Streptozotocin-...

Full description

Bibliographic Details
Main Authors:	Wenjuan Liu, Wei Gong, Min He, Yemei Liu, Yeping Yang, Meng Wang, Meng Wu, Shizhe Guo, Yifei Yu, Xuanchun Wang, Fei Sun, Yiming Li, Linuo Zhou, Shengmei Qin, Zhaoyun Zhang
Format:	Article
Language:	English
Published:	Hindawi Limited 2018-01-01
Series:	Journal of Diabetes Research
Online Access:	http://dx.doi.org/10.1155/2018/9232065

Similar Items

Exogenous Pancreatic Kallikrein Improves Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetes
by: Meng Wu, et al.
Published: (2018-08-01)

Beneficial effects of spironolactone on glomerular injury in streptozotocin-induced diabetic rats
by: Jun Yuan, et al.
Published: (2007-09-01)

The association of erythrocyte sedimentation rate, high-sensitivity C-reactive protein and diabetic kidney disease in patients with type 2 diabetes
by: Shizhe Guo, et al.
Published: (2020-07-01)

Dihydromyricetin Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Mice
by: Bin Wu, et al.
Published: (2017-01-01)

Skimmin protects diabetic cardiomyopathy in streptozotocin‐induced diabetic rats
by: Rui‐Kai Liang, et al.
Published: (2021-02-01)

Thymoquinone Attenuates Cardiomyopathy in Streptozotocin-Treated Diabetic Rats
by: Mustafa S. Atta, et al.
Published: (2018-01-01)

Spironolactone ameliorates podocytic adhesive capacity via restoring integrin α3 expression in streptozotocin-induced diabetic rats
by: Shan Lin, et al.
Published: (2010-09-01)

Spironolactone rescues Dot1a-Af9-mediated repression of endothelin-1 and improves kidney injury in streptozotocin-induced diabetic rats.
by: Qiaoling Zhou, et al.
Published: (2012-01-01)

Effects of Spironolactone on Proteinuria of Patients with Type 2 Diabetes
by: Mohamad Karami Horestani, et al.
Published: (2012-10-01)

Outcomes of Spironolactone Withdrawal in Dilated Cardiomyopathy With Improved Ejection Fraction
by: Yanjia Chen, et al.
Published: (2021-09-01)

Modification of ventriculo–arterial coupling by spironolactone in nonischemic dilated cardiomyopathy
by: Mark A. Lawson, et al.
Published: (2021-04-01)

L-glutamine supplementation prevents the development of experimental diabetic cardiomyopathy in streptozotocin-nicotinamide induced diabetic rats.
by: Sachin L Badole, et al.
Published: (2014-01-01)

FTZ Ameliorates Diabetic Cardiomyopathy by Inhibiting Inflammation and Cardiac Fibrosis in the Streptozotocin-Induced Model
by: Lexun Wang, et al.
Published: (2021-01-01)

Isolated downregulation of HCN2 in ventricles of rats with streptozotocin-induced diabetic cardiomyopathy
by: Katarina Hadova, et al.
Published: (2021-03-01)

Determination of peripheral neuropathy prevalence and associated factors in Chinese subjects with diabetes and pre-diabetes - ShangHai Diabetic neuRopathy Epidemiology and Molecular Genetics Study (SH-DREAMS).
by: Bin Lu, et al.
Published: (2013-01-01)

EFFECT OF SPIRONOLACTONE ON HEART RATE VARIABILITY (HRV) IN DIABETIC PATIENTS
by: Ramin Heydari, et al.
Published: (2010-12-01)

Effects of Spironolactone and Losartan on Diabetic Nephropathy in a Type 2 Diabetic Rat Model
by: Mi Young Lee, et al.
Published: (2011-04-01)

Improvement of cognitive impairment in female type 2 diabetes mellitus mice by spironolactone
by: Akiko Sakata, et al.
Published: (2012-03-01)

Forskolin Protected against Streptozotocin-Induced Diabetic Cardiomyopathy via Inhibition of Oxidative Stress and Cardiac Fibrosis in Mice
by: Xu Zhang, et al.
Published: (2021-01-01)

Treadmill exercise alleviates diabetic cardiomyopathy by suppressing plasminogen activator inhibitor expression and enhancing eNOS in streptozotocin-induced male diabetic rats
by: Wang Chengji, et al.
Published: (2018-04-01)

Evaluation of spironolactone plus hydrochlorothiazide in reducing proteinuria in type 2 diabetic nephropathy
by: Ali Momeni, et al.
Published: (2015-03-01)

Decrease of Klotho in the Kidney of Streptozotocin-Induced Diabetic Rats
by: Meng-Fu Cheng, et al.
Published: (2010-01-01)

Mitochondrial aldehyde dehydrogenase (ALDH2) protects against streptozotocin-induced diabetic cardiomyopathy: role of GSK3β and mitochondrial function
by: Zhang Yingmei, et al.
Published: (2012-04-01)

Effects and mechanisms of PSS-loaded nanoparticles on coronary microcirculation dysfunction in streptozotocin-induced diabetic cardiomyopathy rats
by: Yongjun Mao, et al.
Published: (2020-01-01)

Cardio-Protective Role of Gingerol along with Prominent Anti-Diabetic Cardiomyopathy Action in A Streptozotocin-Induced Diabetes Mellitus Rat Model
by: Li-Ya Yu, et al.
Published: (2017-08-01)

Curcumin alleviates diabetic cardiomyopathy in experimental diabetic rats.
by: Wei Yu, et al.
Published: (2012-01-01)

Fisetin protects against streptozotocin-induced diabetic cardiomyopathy in rats by suppressing fatty acid oxidation and inhibiting protein kinase R
by: Jozaa Z. ALTamimi, et al.
Published: (2021-01-01)

Antihyperglycemic Effect of Ganoderma Lucidum Polysaccharides on Streptozotocin-Induced Diabetic Mice
by: Zhijian Zhong, et al.
Published: (2011-09-01)

Naringin ameliorates cognitive deficits in streptozotocin-induced diabetic rats
by: Xianchu Liu, et al.
Published: (2016-04-01)

Edaravone protect against retinal damage in streptozotocin-induced diabetic mice.
by: Dongqing Yuan, et al.
Published: (2014-01-01)

High-Fat Diet Alters the Intestinal Microbiota in Streptozotocin-Induced Type 2 Diabetic Mice
by: Sheng Liu, et al.
Published: (2019-06-01)

Ergosterol Alleviates Kidney Injury in Streptozotocin-Induced Diabetic Mice
by: Li Ang, et al.
Published: (2015-01-01)

Cichorium intybus attenuates streptozotocin induced diabetic cardiomyopathy via inhibition of oxidative stress and inflammatory response in rats
by: Sharma Manju, et al.
Published: (2019-11-01)

Novel role of spironolactone in the therapy of resistant hypertension: Spironolactone and resistant hypertension
by: Dragojević-Simić Viktorija, et al.
Published: (2019-01-01)

The Protective Effect of Fucoidan in Rats with Streptozotocin-Induced Diabetic Nephropathy
by: Jing Wang, et al.
Published: (2014-05-01)

Puerarin attenuated early diabetic kidney injury through down-regulation of matrix metalloproteinase 9 in streptozotocin-induced diabetic rats.
by: Yifei Zhong, et al.
Published: (2014-01-01)

Total saponin of Dioscoreae hypoglaucae rhizoma ameliorates streptozotocin-induced diabetic nephropathy
by: Guo C, et al.
Published: (2016-02-01)

Icariside II ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats
by: Tian W, et al.
Published: (2015-09-01)

Berberine Nanosuspension Enhances Hypoglycemic Efficacy on Streptozotocin Induced Diabetic C57BL/6 Mice
by: Zhiping Wang, et al.
Published: (2015-01-01)

Regulation of Klotho and FGF receptors (FGFRs) in the kidney of streptozotocin-induced diabetic rats
by: Meng-FuCheng, et al.
Published: (2013)